ATS 2018 International Conference - Mobile

David Budd

PhD

Novartis Institutes for Biomedical Research

Session(s)

Fevipiprant, a Potent Selective Prostaglandin D2 Receptor 2 (DP2) Antagonist, Dose-Depende...
Sunday, May 20 11:15 AM - 1:00 PM